BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27472478)

  • 1. Partly Fermented Infant Formulae With Specific Oligosaccharides Support Adequate Infant Growth and Are Well-Tolerated.
    Huet F; Abrahamse-Berkeveld M; Tims S; Simeoni U; Beley G; Savagner C; Vandenplas Y; Hourihane JO
    J Pediatr Gastroenterol Nutr; 2016 Oct; 63(4):e43-53. PubMed ID: 27472478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised controlled trial demonstrates that fermented infant formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides reduces the incidence of infantile colic.
    Vandenplas Y; Ludwig T; Bouritius H; Alliet P; Forde D; Peeters S; Huet F; Hourihane J
    Acta Paediatr; 2017 Jul; 106(7):1150-1158. PubMed ID: 28328065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fermented infant formula (with Bifidobacterium breve C50 and Streptococcus thermophilus O65) with prebiotic oligosaccharides is safe and modulates the gut microbiota towards a microbiota closer to that of breastfed infants.
    Béghin L; Tims S; Roelofs M; Rougé C; Oozeer R; Rakza T; Chirico G; Roeselers G; Knol J; Rozé JC; Turck D
    Clin Nutr; 2021 Mar; 40(3):778-787. PubMed ID: 32893049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal Tolerance, Growth and Safety of a Partly Fermented Formula with Specific Prebiotics in Healthy Infants: A Double-Blind, Randomized, Controlled Trial.
    Rodriguez-Herrera A; Mulder K; Bouritius H; Rubio R; Muñoz A; Agosti M; Lista G; Corvaglia L; Ludwig T; Abrahamse-Berkeveld M; Perez-Navero JL
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31284424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Partly Fermented Infant Formula with Postbiotics Including 3'-GL, Specific Oligosaccharides, 2'-FL, and Milk Fat Supports Adequate Growth, Is Safe and Well-Tolerated in Healthy Term Infants: A Double-Blind, Randomised, Controlled, Multi-Country Trial.
    Vandenplas Y; de Halleux V; Arciszewska M; Lach P; Pokhylko V; Klymenko V; Schoen S; Abrahamse-Berkeveld M; Mulder KA; Porcel Rubio R; On Behalf Of The Voyage Study Group
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33233658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infant formula containing galacto-and fructo-oligosaccharides and
    Abrahamse-Berkeveld M; Alles M; Franke-Beckmann E; Helm K; Knecht R; Köllges R; Sandner B; Knol J; Ben Amor K; Bufe A
    J Nutr Sci; 2016; 5():e42. PubMed ID: 28620469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on faecal microbiota of dietary and acidic oligosaccharides in children during partial formula feeding.
    Magne F; Hachelaf W; Suau A; Boudraa G; Bouziane-Nedjadi K; Rigottier-Gois L; Touhami M; Desjeux JF; Pochart P
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):580-8. PubMed ID: 18493215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides.
    Scholtens PA; Alliet P; Raes M; Alles MS; Kroes H; Boehm G; Knippels LM; Knol J; Vandenplas Y
    J Nutr; 2008 Jun; 138(6):1141-7. PubMed ID: 18492847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and Safety of an Anti-Regurgitation Formula Containing Locust Bean Gum, Pre-, and Postbiotics: A Multi-Country Multi-Center Prospective Randomized Controlled Study in Infants with Regurgitation.
    Salvatore S; Klymenko V; Karpushenko Y; Durczak-Hilleman M; Loboda A; Petrashenko V; Olechowski W; Lista G; Meneghin F; Amodio S; Bongers A; Ludwig T; Vandenplas Y
    Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stool characteristics of infants receiving short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides: a review.
    Scholtens PA; Goossens DA; Staiano A
    World J Gastroenterol; 2014 Oct; 20(37):13446-52. PubMed ID: 25309075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of neutral and acidic oligosaccharides on stool viscosity, stool frequency and stool pH in preterm infants.
    Westerbeek EA; Hensgens RL; Mihatsch WA; Boehm G; Lafeber HN; van Elburg RM
    Acta Paediatr; 2011 Nov; 100(11):1426-31. PubMed ID: 21449921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy.
    Schouten B; Van Esch BC; Kormelink TG; Moro GE; Arslanoglu S; Boehm G; Knippels LM; Redegeld FA; Willemsen LE; Garssen J
    Pediatr Allergy Immunol; 2011 Aug; 22(5):537-42. PubMed ID: 21771085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of enteral supplementation of a prebiotic mixture of non-human milk galacto-, fructo- and acidic oligosaccharides on intestinal permeability in preterm infants.
    Westerbeek EA; van den Berg A; Lafeber HN; Fetter WP; van Elburg RM
    Br J Nutr; 2011 Jan; 105(2):268-74. PubMed ID: 20863418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth and safety evaluation of infant formulae containing oligosaccharides derived from bovine milk: a randomized, double-blind, noninferiority trial.
    Meli F; Puccio G; Cajozzo C; Ricottone GL; Pecquet S; Sprenger N; Steenhout P
    BMC Pediatr; 2014 Dec; 14():306. PubMed ID: 25527244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplementation of dietary non-digestible oligosaccharides from birth onwards improve social and reduce anxiety-like behaviour in male BALB/c mice.
    Szklany K; Wopereis H; de Waard C; van Wageningen T; An R; van Limpt K; Knol J; Garssen J; Knippels LMJ; Belzer C; Kraneveld AD
    Nutr Neurosci; 2020 Nov; 23(11):896-910. PubMed ID: 30871432
    [No Abstract]   [Full Text] [Related]  

  • 16. Exploration of basal immune parameters in healthy infants receiving an infant milk formula supplemented with prebiotics.
    Raes M; Scholtens PA; Alliet P; Hensen K; Jongen H; Boehm G; Vandenplas Y; Rummens JL
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 2):e377-85. PubMed ID: 20003064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Tolerance of a Novel Anti-Regurgitation Formula: A Double-Blind, Randomized, Controlled Trial.
    Bellaiche M; Ludwig T; Arciszewska M; Bongers A; Gomes C; Świat A; Dakhlia F; Piollet A; Oozeer R; Vandenplas Y
    J Pediatr Gastroenterol Nutr; 2021 Nov; 73(5):579-585. PubMed ID: 34417399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A partially hydrolyzed formula with synbiotics supports adequate growth and is well tolerated in healthy, Chinese term infants: A double-blind, randomized controlled trial.
    Wang Y; Li Z; Wu JL; Zhang L; Liu M; Tan M; Botma A; Liu M; Mulder KA; Abrahamse-Berkeveld M; Cai W
    Nutrition; 2021; 91-92():111472. PubMed ID: 34626956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prebiotic galacto-oligosaccharide, long-chain fructo-oligosaccharide infant formula on serum cholesterol and triacylglycerol levels.
    Alliet P; Scholtens P; Raes M; Hensen K; Jongen H; Rummens JL; Boehm G; Vandenplas Y
    Nutrition; 2007 Oct; 23(10):719-23. PubMed ID: 17664059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Synbiotic on the Gut Microbiota of Cesarean Delivered Infants: A Randomized, Double-blind, Multicenter Study.
    Chua MC; Ben-Amor K; Lay C; Neo AGE; Chiang WC; Rao R; Chew C; Chaithongwongwatthana S; Khemapech N; Knol J; Chongsrisawat V
    J Pediatr Gastroenterol Nutr; 2017 Jul; 65(1):102-106. PubMed ID: 28644357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.